JESSICA WOEPPEL: Open Payments
NPI 1922874981 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,049 in 41 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,319 · 2025 $1,049
Food & beverage: $1,049
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $157 |
| Procept Biorobotics Corporation | 3 | $151 |
| Astellas Pharma US Inc | 5 | $126 |
| ABBVIE INC. | 5 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $88 |
| UROGEN PHARMA, INC. | 2 | $57 |
| ACCORD HEALTHCARE, INC. | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Ferring Pharmaceuticals Inc. | 2 | $38 |
| Endo USA, Inc. | 2 | $35 |
Products named: GEMTESA, AQUABEAM ROBOTIC SYSTEM, Xtandi, Nubeqa, BOTOX, JELMYTO, Camcevi, LUPRON DEPOT.
Industry payments across UT — which companies pay providers there.
